פריוויג'ן

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

IMMUNOGLOBULINS, NORMAL HUMAN

Disponible des:

CSL BEHRING LTD., ISRAEL

Codi ATC:

J06BA02

formulario farmacéutico:

תמיסה לאינפוזיה

Composición:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Vía de administración:

תוך-ורידי

tipo de receta:

מרשם נדרש

Fabricat per:

CSL BEHRING AG, SWITZERLAND

Grupo terapéutico:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Área terapéutica:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

indicaciones terapéuticas:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Data d'autorització:

2016-06-30